Type 1 Diabetes Market Report

Global and Region Type 1 Diabetes Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：191
  • REPORT CODE：GMM917142
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Type 1 Diabetes market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Type 1 Diabetesmarket, defines the market attractiveness level of Type 1 Diabetes market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Type 1 Diabetes industry, describes the types of Type 1 Diabetes market, the applications of major players and the market size, and deeply analyzes the current situation of the global Type 1 Diabetes market and the development prospects and opportunities of Type 1 Diabetes industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Type 1 Diabetes market in Chapter 13.

    By Player:

    • Medtronic

    • Smiths Medical

    • BD

    • Merck

    • AstraZeneca

    • Johnson & Johnson

    • Roche

    • Eli Lilly

    • Bayer

    • Abbott

    • Pfizer

    By Type:

    • Rapid-acting

    • Long-acting

    • Premix

    By End-User:

    • Hospitals

    • Diagnostic clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Type 1 Diabetes Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Type 1 Diabetes Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Type 1 Diabetes Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Type 1 Diabetes Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Type 1 Diabetes Market Analysis and Outlook to 2022

    • 7.1 Global Type 1 Diabetes Consumption (2017-2022)

    • 7.2 United States Type 1 Diabetes Consumption (2017-2022)

    • 7.3 Europe Type 1 Diabetes Consumption (2017-2022)

    • 7.4 China Type 1 Diabetes Consumption (2017-2022)

    • 7.5 Japan Type 1 Diabetes Consumption (2017-2022)

    • 7.6 India Type 1 Diabetes Consumption (2017-2022)

    • 7.7 South Korea Type 1 Diabetes Consumption (2017-2022)

    8 Region and Country-wise Type 1 Diabetes Market Analysis and Outlook to 2028

    • 8.1 Global Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.2 United States Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.3 Europe Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.4 China Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.5 Japan Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.6 India Type 1 Diabetes Consumption Forecast (2022-2028)

    • 8.7 South Korea Type 1 Diabetes Consumption Forecast (2022-2028)

    9 Global Type 1 Diabetes Market Outlook by Types and Applications to 2022

    • 9.1 Global Type 1 Diabetes Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rapid-acting Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Long-acting Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Premix Consumption and Growth Rate (2017-2022)

    • 9.2 Global Type 1 Diabetes Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic clinics Consumption and Growth Rate (2017-2022)

    10 Global Type 1 Diabetes Market Outlook by Types and Applications to 2028

    • 10.1 Global Type 1 Diabetes Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Rapid-acting Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Long-acting Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Premix Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Type 1 Diabetes Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Type 1 Diabetes Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Type 1 Diabetes Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Type 1 Diabetes Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Type 1 Diabetes Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Type 1 Diabetes Market Competitive Analysis

    • 14.1 Medtronic

      • 14.1.1 Medtronic Company Details

      • 14.1.2 Medtronic Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medtronic Type 1 Diabetes Product and Service

    • 14.2 Smiths Medical

      • 14.2.1 Smiths Medical Company Details

      • 14.2.2 Smiths Medical Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Smiths Medical Type 1 Diabetes Product and Service

    • 14.3 BD

      • 14.3.1 BD Company Details

      • 14.3.2 BD Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 BD Type 1 Diabetes Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Type 1 Diabetes Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca Type 1 Diabetes Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Type 1 Diabetes Product and Service

    • 14.7 Roche

      • 14.7.1 Roche Company Details

      • 14.7.2 Roche Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Roche Type 1 Diabetes Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Type 1 Diabetes Product and Service

    • 14.9 Bayer

      • 14.9.1 Bayer Company Details

      • 14.9.2 Bayer Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer Type 1 Diabetes Product and Service

    • 14.10 Abbott

      • 14.10.1 Abbott Company Details

      • 14.10.2 Abbott Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Abbott Type 1 Diabetes Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Type 1 Diabetes Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Type 1 Diabetes

    • Figure Type 1 Diabetes Picture

    • Table Global Type 1 Diabetes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 1 Diabetes Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 1 Diabetes Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Type 1 Diabetes Consumption by Country (2017-2022)

    • Figure United States Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Table Europe Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure China Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Japan Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure India Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure South Korea Type 1 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Diabetes Consumption Forecast by Country (2022-2028)

    • Figure United States Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rapid-acting Consumption and Growth Rate (2017-2022)

    • Figure Global Long-acting Consumption and Growth Rate (2017-2022)

    • Figure Global Premix Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid-acting Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long-acting Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Premix Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Type 1 Diabetes Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Type 1 Diabetes Export by Region (Top 5 Countries) (2017-2028)

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Type 1 Diabetes Product and Service

    • Table Smiths Medical (Foundation Year, Company Profile and etc.)

    • Table Smiths Medical Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Smiths Medical Type 1 Diabetes Product and Service

    • Table BD (Foundation Year, Company Profile and etc.)

    • Table BD Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Type 1 Diabetes Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Type 1 Diabetes Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Type 1 Diabetes Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Type 1 Diabetes Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Type 1 Diabetes Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Type 1 Diabetes Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Type 1 Diabetes Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Type 1 Diabetes Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Type 1 Diabetes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Type 1 Diabetes Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US